Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.

There are two primary types of hypertrophy: physiological and pathological.

1. Physiological Hypertrophy

Physiological hypertrophy is a normal, beneficial adaptation to increased workload or hormonal signals. It generally enhances the function of the tissue or organ and does not cause harm.

For example, physiological hypertrophy in skeletal muscle occurs in response to consistent resistance training or mechanical overload, which triggers molecular signaling pathways, particularly the IGF-1/Akt/mTOR pathway. This activation promotes protein synthesis, enhances contractile protein production, and facilitates muscle fiber growth, leading to increases in muscle size, strength, and endurance. Notably, this type of hypertrophy is reversible if the workload is reduced.

2. Pathological Hypertrophy

Pathological hypertrophy occurs in response to chronic stress, such as pressure or volume overload, and certain diseases. Initially compensatory, it often leads to tissue dysfunction and disease over time.

For example, cardiac hypertrophy typically develops from chronic hypertension or valvular heart disease, where the heart must pump against increased resistance. This sustained effort enlarges cardiac muscle cells in the myocardium, temporarily maintaining cardiac output. However, prolonged hypertrophy results in thickened, stiff heart walls, compromising the heart’s ability to relax and fill during diastole, ultimately increasing the risk of heart failure.

Certain hormones and growth factors also contribute to hypertrophy. For example, anabolic hormones like testosterone stimulate physiological skeletal muscle growth. However, growth factors such as transforming growth factor-beta (TGF-β) are often involved in pathological hypertrophy.